Table 4.
Donor information for the validation set
| Casea | Age | Sex | Disease | Stageb |
|---|---|---|---|---|
| T6 | 58 | F | Pancreatic adenocarcinoma | IV |
| T7 | 53 | M | Pancreatic adenocarcinoma | III |
| T8 | 64 | M | Pancreatic adenocarcinoma | II |
| T9 | 51 | M | Pancreatic adenocarcinoma | III |
| T10 | 64 | F | Pancreatic adenocarcinoma | III |
| T11 | 81 | M | Pancreatic adenocarcinoma | III |
| T12 | 59 | M | Pancreatic adenocarcinoma | II |
| T13 | 63 | M | Pancreatic adenocarcinoma | III |
| T14 | 69 | M | Pancreatic adenocarcinoma | III |
| T15 | 48 | M | Pancreatic adenocarcinoma | III |
| T16 | 67 | M | Pancreatic adenocarcinoma | IV |
| T17 | 56 | M | Pancreatic adenocarcinoma | IV |
| T18 | 37 | F | Pancreatic adenocarcinoma | III |
| T19 | 58 | F | Pancreatic adenocarcinoma | III |
| T20 | 52 | F | Pancreatic adenocarcinoma | IV |
| T21 | 62 | F | Pancreatic adenocarcinoma | I |
| N6 | 45 | F | Serous cystic pancreatic neoplasm | |
| N7 | 54 | F | Somatostatin cell tumor | |
| N8 | 60 | M | Islet cell tumor | |
| N9 | 54 | M | Mucinous cystic pancreatic neoplasm | |
| N10 | 36 | M | Pseudocyst | |
| N11 | 36 | F | Serous cystic pancreatic neoplasm | |
| N12 | 70 | M | Pseudocyst | |
| N13 | 53 | M | Pancreatitis | |
| N14 | 59 | F | Pancreatitis | |
| N15 | 50 | F | Chronic pancreatitis | |
| N16 | 48 | F | Intraductal papillary mucinous neoplasm | |
| N17 | 37 | F | Normal | |
| N18 | 54 | M | Normal | |
| N19 | 64 | M | Normal | |
| N20 | 72 | M | Normal | |
| N21 | 56 | F | Normal |
a T: pancreatic cancer patients; N: non-cancer bearing donors.
b The Union International Contre Le Cancer(UICC) classification.